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Introduction
In 2014, the first national report providing surveillance
data for antibiotic consumption in England was pub-
lished by the English Surveillance Programme for Anti-
microbial Utilisation and Resistance (ESPAUR) [1].
Rx-info and IMS Health are commercial organisations
specialising in the provision of prescribing data for
healthcare. Data from IMS Health was used to collate
information on antibiotic use in secondary care for the
ESPAUR report. The report showed considerable varia-
bility in the extent of antibiotic prescribing across differ-
ent areas within England. While IMS Health and Rx-info
each have formal internal quality assurance processes,
there has been no external validation of the data when
used for the purpose of comparison or benchmarking.
The National Health Service (NHS) England will include
validation of hospital prescribing data as part of the anti-
microbial quality premium (financial reward for improve-
ments in quality of care) in 2015/16.
Objectives
To develop a national protocol for validating antimicro-
bial consumption data in acute NHS hospitals in
England.
Methods
A validation protocol was designed and piloted in acute
NHS hospitals. Each was sent the protocol along with a
workbook to enable each hospital to submit antimicro-
bial consumption data from their own pharmacy system.
These data were analysed alongside that from IMS
Health and Rx-info. Participating hospitals were also
sent a questionnaire to gather feedback on the pilot vali-
dation protocol to help inform the final national
protocol.
Results
Forty-five (out of acute 156) NHS Trusts participated in
the pilot. The pilot protocol and questionnaire feedback
enabled the development of a national validation proto-
col which was published in March 2015.
Conclusion
All acute NHS hospitals in England will be encouraged to
use the national protocol to validate antimicrobial pre-
scribing data to ensure correct and meaningful data for
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